Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Immunity|December 15, 2010
An oscillatory switch in mTOR kinase activity sets regulatory T cell responsivenessClaudio Procaccini, Veronica De Rosa, Mario Galgani, et al.International Journal of Molecular Sciences|April 13, 2023
Antibody Profile, Gene Expression and Serum Cytokines in At-Risk Infants before the Onset of Celiac DiseaseRenata Auricchio, Martina Galatola, Donatella Cielo, et al.Therapeutic Advances in Neurological Disorders|March 1, 2019
Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosisMarcello Moccia, Antonio Capacchione, Roberta Lanzillo, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2012
Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responsesClaudio Procaccini, Veronica De Rosa, Mario Galgani, et al.International Journal of Molecular Sciences|October 13, 2021
16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal CancerCarmela Nardelli, Ilaria Granata, Marcella Nunziato, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 24, 2021
A novel smaller β-defensin-derived peptide is active against multidrug-resistant bacterial strainsRoberta Colicchio, Ersilia Nigro, Irene Colavita, et al.Clinical Immunology (Orlando, Fla.)|August 22, 2017
Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1aRoberta Lanzillo, Fortunata Carbone, Mario Quarantelli, et al.Immunity|February 18, 2016
The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic RequirementsClaudio Procaccini, Fortunata Carbone, Dario Di Silvestre, et al.Diabetologia|May 24, 2022
High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune diseaseSara Bruzzaniti, Erica Piemonte, Enza Mozzillo, et al.Biomolecules|February 25, 2022
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple SclerosisFederica Azzolini, Luana Gilio, Luigi Pavone, et al.Pageof 5